Pharma: what GMP auditors really think of your spreadsheets

Spreadsheets, shared drives, checklists filled in by hand: why they make GMP auditors uneasy, and how a small pharma company can prove its compliance simply.

Table of contents

Two quality managers. Three validation binders kept in parallel. And one question from the inspector that nobody can answer with certainty: "the version you are showing me — was it the one in force at the last inspection?"

In pharmaceuticals, that hesitation is expensive.

In pharma, compliance is the licence to operate

In most sectors, a finding in an audit leads to an action plan. In pharma and the life sciences it can block a batch, delay a market authorisation, or put an authorisation itself at risk. Compliance is not an option: it is the condition for working at all.

And yet, in a great many smaller companies in the sector, the documentary load still rests on spreadsheets, shared drives and checklists filled in by hand.

What an auditor sees in a spreadsheet

Not bad faith. But three weaknesses that make them wary:

  • No reliable traceability. Who changed what, and when? An overwritten file does not tell its own story.
  • No reference version. When several copies are in circulation, which one is authoritative?
  • No link between the pieces. The non-conformity, its analysis, the corrective action and the check on its effectiveness live in separate files.

The data-integrity principles expected in a GMP environment — data that is attributable, legible, contemporaneous, original and accurate — are hard to demonstrate with those tools.

The three processes to secure first

  1. Non-conformities. Opening, analysis, corrective and preventive action, closure: one single file, one complete history.
  2. Supplier qualification. The status of each supplier, the documents, the audits, the requalification dates, visible at a glance.
  3. Validation workflows. Who approves, in what order, with what evidence. No more routing by email.

The cost of poor quality

Rework, documentary gaps, weeks spent preparing for audits: for a pharma company turning over €10M, quality-related costs run into hundreds of thousands of euros every year. A large part of that comes not from the findings themselves, but from the time spent documenting them and finding them again.

How Klaro Cards goes about it

Klaro Cards brings non-conformity tracking, supplier qualification and validation workflows together in a single, audit-ready system with complete traceability. Four Quality & compliance modules are available for the sector, to be taken separately according to your priorities.

Table of contents

Could you prove it tomorrow morning?

Explore our solutions